Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanno Glimm

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Nature Communications|January 19, 2026
The Knowledge Connector decision support system for multiomics-based precision oncologyDaniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Nature Communications|January 19, 2026
The Knowledge Connector decision support system for multiomics-based precision oncologyDaniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue SarcomaPriya Chudasama, Marcus Renner, Melanie Straub, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
Pageof 15